[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2018 | 144 pages | ID: R2E3F5B894CEN
MarketLine

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketline's Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Recipharm AB since January2007.

Synopsis

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Recipharm AB's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Recipharm AB. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope
  • Provides intelligence on Recipharm AB's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
  • Detailed reports of various financial transactions undertaken by Recipharm AB and its subsidiaries since 2007.
  • Information about key financial and legal advisors for Recipharm AB's financial deals transactions.
  • Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
  • Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
  • Form an independent opinion about Recipharm AB’s growth strategies through the organic and inorganic activities undertaken since 2007.
  • Track your competitors’ business structure and growth strategies.
COMPANY OVERVIEW AND KEY FACTS
TARGETS AND PARTNERS
MERGERS & ACQUISITIONS
Mergers and Acquisitions - Overview
Mergers and Acquisitions - Deal reports
PARTNERSHIP
Partnership - Overview
Partnership - Deal reports
CAPITAL RAISING
Capital Raising - Overview
Capital Raising - Deal reports
DIVESTMENTS
Divestments - Overview
Divestments - Deal reports
PRIVATE EQUITY & OWNERSHIP
Private Equity and Ownership - Deal reports
APPENDIX
Contact Us
About MarketLine Financial Deals Database
Deal Definition and Methodology
About MarketLine

LIST OF TABLES

Table 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Table 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Table 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Table 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Table 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Table 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Table 7: Recipharm AB divestments volume and value trend (2014-YTD2018)

LIST OF FIGURES

Figure 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Figure 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Figure 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Figure 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Figure 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Figure 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Figure 7: Recipharm AB divestments volume and value trend (2014-YTD2018)


More Publications